A. The UpSmith Pharmaceutical Corporation announced the successful development of a vaccine that can prevent certain forms of cancer. The cost of each dose of the vaccine is inexpensiveas low as $1 by some estimates. The retail price of the vaccine per dose, however, is $100.

• UpSmith defends this high price as a way to recover research and development efforts connected with the cancer vaccine that spanned over 20 years.
• Is the firm correct in incorporating these R & D expenditures into the vaccines sales price?